Experimental protection of diabetic mice against lethal P. aeruginosa infection by bacteriophage

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Shivshetty, Nagaveni ^a   Hosamani, Rajeshwari ^a   Ahmed, Liyakat ^b   Oli, Ajay Kumar ^a   Sannauallah, Syed ^b   Sharanbassappa, Shivshetty ^c   Patil, S A ^d   Kelmani, Chandrakanth R ^a  

^a GULBARGA UNIVERSITY   (India)

^b Luqman College of Pharmacy   (India)

^c M R MEDICAL COLLEGE   (India)

^d NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGE DNA; GLIPIZIDE; GLUCOSE; IMIPENEM;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIOPHAGE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PSEUDOMONAS INFECTION; RESTRICTION MAPPING; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; ANTIBIOTIC RESISTANCE; DIABETES MELLITUS, EXPERIMENTAL; GENETICS; HUMAN; MICROBIOLOGY; NONOBESE DIABETIC MOUSE; PATHOGENICITY; PATHOLOGY; PSEUDOMONAS AERUGINOSA; SEPSIS; VIROLOGY;

ANIMALS; BACTERIOPHAGES; DIABETES MELLITUS, EXPERIMENTAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MICE; MICE, INBRED NOD; PSEUDOMONAS AERUGINOSA; SEPSIS;

EID: 84903648268     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/793242     Document Type: Article

References (30)

1. Livermore D. M., Of Pseudomonas, porins, pumps and carbapenems. Journal of Antimicrobial Chemotherapy 2001 47 3 247 250 2-s2.0-0035093095 (Pubitemid 32229565)
2. Woodford N., Turton J. F., Livermore D. M., Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiology Reviews 2011 35 5 736 755 2-s2.0-79960959584 10.1111/j.1574-6976.2011.00268.x
3. Wheat J., Stephen D. A., Marietta H., Clyde B. K., Jean A. S., Thomas K., Naomi F., James N., Diabetic foot infections bacteriologic analysis. Archives of Internal Medicine 1986 146 10 1935 1940
4. Joshi N., Caputo G. M., Weitekamp M. R., Karchmer A. W., Infections in patients with diabetes mellitus. New England Journal of Medicine 1999 341 25 1906 1912 2-s2.0-0033576806 10.1056/NEJM199912163412507
5. Miȩdzybrodzki R., Borysowski J., Weber-Da̧browska B., Fortuna W., Letkiewicz S., Szufnarowski K., Pawełczyk Z., Rogóz P., Kłak M., Wojtasik E., Górski A., Clinical aspects of phage therapy. Advances in Virus Research 2012 83 73 121 2-s2.0-84862897331 10.1016/B978-0-12-394438-2.00003-7
6. Biswas B., Adhya S., Washart P., Paul B., Trostel A. N., Powell B., Carlton R., Merril C. R., Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infection and Immunity 2002 70 1 204 210 2-s2.0-0036139176 10.1128/IAI.70.1.204-210.2002 (Pubitemid 34028619)
7. Carvalho E. N., Carvalho N. A., Ferreira L. M., Experimental model of induction of diabetes mellitus in rats. Acta Cirurgica Brasileira 2003 18
8. Merril C. R., Biswas B., Carlton R., Jensen N. C., Creed G. J., Zullo S., Adhya S., Long-circulating bacteriophage as antibacterial agents. Proceedings of the National Academy of Sciences of the United States of America 1996 93 8 3188 3192 2-s2.0-0029866651 10.1073/pnas.93.8.3188 (Pubitemid 26125592)
9. Smith H. W., Huggins M. B., Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. Journal of General Microbiology 1982 128 2 307 318 2-s2.0-0020024790 (Pubitemid 12159900)
10. Brans T. A., Dutrieux R. P., Hoekstra M. J., Kreis R. W., Du Pont J. S., Histopathological evaluation of scalds and contact burns in the pig model. Burns 1994 20 1 S48 S51 2-s2.0-0028302892
11. Chugani S., Greenberg E. P., The influence of human respiratory epithelia on Pseudomonas aeruginosa gene expression. Microbial Pathogenesis 2007 42 1 29 35 2-s2.0-33845430014 10.1016/j.micpath.2006.10.004 (Pubitemid 44909727)
12. James S. T., Infectious complications in patients with diabetes mellitus. International Diabetes Monitor 2000 12 1 7
13. Like A. A., Rossini A. A., Streptozotocin induced pancreatic insulitis: new model of diabetes mellitus. Science 1976 193 4251 415 417 2-s2.0-0017179001
14. Leehey D. J., Singh A. K., Bast J. P., Sethupathi P., Singh R., Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats. Translational Research 2008 151 4 208 216 2-s2.0-40849120442 10.1016/j.trsl.2008.01.003
15. Rich J., Lee J. C., The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes 2005 54 10 2904 2910 2-s2.0-25844487822 10.2337/diabetes.54.10.2904 (Pubitemid 41401085)
16. Park S., Rich J., Hanses F., Lee J. C., Defects in innate immunity predispose C57BL/6J-Lepr db/Lepr db Mice to infection by Staphylococcus aureus. Infection and Immunity 2009 77 3 1008 1014 2-s2.0-62449240826 10.1128/IAI.00976-08
17. Gadepalli R., Dhawan B., Sreenivas V., Kapil A., Ammini A. C., Chaudhry R., A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006 29 8 1727 1732 2-s2.0-33746655693 10.2337/dc06-0116 (Pubitemid 44156621)
18. Stone R., Bacteriophage therapy. Stalin's forgotten cure. Science 2002 298 5594 728 731 2-s2.0-0037174764
19. Bruttin A., Brüssow H., Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrobial Agents and Chemotherapy 2005 49 7 2874 2878 2-s2.0-21444458163 10.1128/AAC.49.7.2874-2878. 2005 (Pubitemid 40917605)
20. Matsuzaki S., Yasuda M., Nishikawa H., Kuroda M., Ujihara T., Shuin T., Shen Y., Jin Z., Fujimoto S., Nasimuzzaman M. D., Wakiguchi H., Sugihara S., Sugiura T., Koda S., Muraoka A., Imai S., Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage φ MR11. Journal of Infectious Diseases 2003 187 4 613 624 2-s2.0-0037442798 10.1086/374001 (Pubitemid 36250025)
21. Soothill J. S., Treatment of experimental infections of mice with bacteriophages. Journal of Medical Microbiology 1992 37 4 258 261 2-s2.0-0026673701
22. Wright G. D., Bacterial resistance to antibiotics: enzymatic degradation and modification. Advanced Drug Delivery Reviews 2005 57 10 1451 1470 2-s2.0-22144476125 10.1016/j.addr.2005.04.002 (Pubitemid 40984601)
23. Merabishvili M., Pirnay J.-P., Verbeken G., Chanishvili N., Tediashvili M., Lashkhi N., Glonti T., Krylov V., Mast J., Van Parys L., Lavigne R., Volckaert G., Mattheus W., Verween G., De Corte P., Rose T., Jennes S., Zizi M., De Vos D., Vaneechoutte M., Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE 2009 4 3 2-s2.0-64049105821 10.1371/journal.pone.0004944 e4944
24. Denou E., Bruttin A., Barretto C., Ngom-Bru C., Brüssow H., Zuber S., T4 phages against Escherichia coli diarrhea: potential and problems. Virology 2009 388 1 21 30 2-s2.0-67349224692 10.1016/j.virol.2009.03.009
25. Ackermann H.-W., Frequency of morphological phage descriptions in the year 2000. Archives of Virology 2001 146 5 843 857 2-s2.0-0035007418 10.1007/s007050170120 (Pubitemid 32480576)
26. Wang J., Hu B., Xu M., Yan Q., Liu S., Zhu X., Sun Z., Reed E., Ding L., Gong J., Li Q. Q., Hu J., Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. International Journal of Molecular Medicine 2006 17 2 309 317 2-s2.0-33644858928
27. Hagens S., Loessner M. J., Application of bacteriophages for detection and control of foodborne pathogens. Applied Microbiology and Biotechnology 2007 76 3 513 519 2-s2.0-34548039230 10.1007/s00253-007-1031-8 (Pubitemid 47283108)
28. Sunagar R., Patil S. A., Chandrakanth R. K., Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice. Research in Microbiology 2010 161 10 854 860 2-s2.0-78649951011 10.1016/j.resmic.2010.09.011
29. Morello E., Saussereau E., Maura D., Huerre M., Touqui L., Debarbieux L., Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS ONE 2011 6 2 2-s2.0-79951928650 10.1371/journal.pone.0016963 e16963
30. Kurzepa-Skaradzinska A., Lusiak-Szelachowska M., Skaradzinski G., Jonczyk-Matysiak E., Weber-Dabrowska B., Zaczek M., Maj T., Slawek A., Rymowicz W., Klak M., Miedzybrodzki R., Gorski A., Influence of bacteriophage preparations on intracellular killing of bacteria by human phagocytes in vitro. Viral Immunology 2013 26 2 150 162 2-s2.0-84876104429 10.1089/vim.2012.0071